These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39009899)

  • 1. Assessing anorectal function in patients with recurrent ulcerative colitis.
    Wu Q; Li T; Deng F; Yao X; Chen X; Jiang Q; Ding X
    Int J Colorectal Dis; 2024 Jul; 39(1):110. PubMed ID: 39009899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorectal manometry in active and quiescent ulcerative colitis.
    Loening-Baucke V; Metcalf AM; Shirazi S
    Am J Gastroenterol; 1989 Aug; 84(8):892-7. PubMed ID: 2756980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
    Gisbert JP; Bermejo F; Pérez-Calle JL; Taxonera C; Vera I; McNicholl AG; Algaba A; López P; López-Palacios N; Calvo M; González-Lama Y; Carneros JA; Velasco M; Maté J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1190-8. PubMed ID: 19291780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.
    Yamamoto T; Shiraki M; Bamba T; Umegae S; Matsumoto K
    Int J Colorectal Dis; 2014 Apr; 29(4):485-91. PubMed ID: 24343276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
    Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis.
    Pakarinen MP; Koivusalo A; Natunen J; Ashorn M; Karikoski R; Aitola P; Rintala RJ; Kolho KL
    Inflamm Bowel Dis; 2010 Mar; 16(3):482-6. PubMed ID: 19685453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorectal Function After Ileo-Rectal Anastomosis Is Better than Pelvic Pouch in Selected Ulcerative Colitis Patients.
    Abdalla M; Norblad R; Olsson M; Landerholm K; Andersson P; Söderholm JD; Andersson R; Myrelid P
    Dig Dis Sci; 2020 Jan; 65(1):250-259. PubMed ID: 31372911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
    Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease.
    Gauss A; Geiss T; Hinz U; Schaefert R; Zwickel P; Zawierucha A; Stremmel W; Klute L
    Medicine (Baltimore); 2016 Apr; 95(16):e3477. PubMed ID: 27100452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.
    Amati L; Passeri ME; Selicato F; Mastronardi ML; Penna A; Jirillo E; Covelli V
    Immunopharmacol Immunotoxicol; 2006; 28(4):665-81. PubMed ID: 17190742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorectal dysfunction in patients with ulcerative colitis: impaired adaptation or enhanced perception?
    Brochard C; Siproudhis L; Ropert A; Mallak A; Bretagne JF; Bouguen G
    Neurogastroenterol Motil; 2015 Jul; 27(7):1032-7. PubMed ID: 25940976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.
    De Vos M; Louis EJ; Jahnsen J; Vandervoort JG; Noman M; Dewit O; Dʼhaens GR; Franchimont D; Baert FJ; Torp RA; Henriksen M; Potvin PM; Van Hootegem PP; Hindryckx PM; Moreels TG; Collard A; Karlsen LN; Kittang E; Lambrecht G; Grimstad T; Koch J; Lygren I; Coche JC; Mana F; Van Gossum A; Belaiche J; Cool MR; Fontaine F; Maisin JM; Muls V; Neuville B; Staessen DA; Van Assche GA; de Lange T; Solberg IC; Vander Cruyssen BJ; Vermeire SA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2111-7. PubMed ID: 23883959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.
    Strid H; Simrén M; Lasson A; Isaksson S; Stridsberg M; Öhman L
    J Crohns Colitis; 2013 Dec; 7(12):e615-22. PubMed ID: 23694857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR
    Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.
    Hanai H; Takeuchi K; Iida T; Kashiwagi N; Saniabadi AR; Matsushita I; Sato Y; Kasuga N; Nakamura T
    Dig Dis Sci; 2004 Sep; 49(9):1438-43. PubMed ID: 15481316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Active Ulcerative Colitis vs Noninflammatory Bowel Disease Proctitis by Transperineal Superb Microvascular Imaging.
    Tokushima K; Jimbo K; Suzuki M; Endo Y; Hibio M; Maruyama K; Kashiwagi K; Arai N; Sato M; Kudo T; Hoshino E; Ohtsuka Y; Shimizu T
    Inflamm Bowel Dis; 2024 Jul; 30(7):1103-1111. PubMed ID: 37643765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbed colonic motility contributes to anorectal symptoms and dysfunction after radiotherapy for carcinoma of the prostate.
    Yeoh EK; Bartholomeusz DL; Holloway RH; Fraser RJ; Botten R; Di Matteo A; Moore JW; Schoeman MN
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):773-80. PubMed ID: 20153122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.